vs
DYNAVAX TECHNOLOGIES CORP（DVAX）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
RESOURCES CONNECTION, INC.的季度营收约是DYNAVAX TECHNOLOGIES CORP的1.2倍（$117.7M vs $94.9M），DYNAVAX TECHNOLOGIES CORP净利率更高（28.4% vs -10.8%，领先39.1%），DYNAVAX TECHNOLOGIES CORP同比增速更快（17.7% vs -19.2%），DYNAVAX TECHNOLOGIES CORP自由现金流更多（$32.6M vs $15.6M），过去两年DYNAVAX TECHNOLOGIES CORP的营收复合增速更高（30.6% vs -11.8%）
Dynavax Technologies Corp是一家处于商业化阶段的生物制药企业，专注于研发和生产针对传染病的创新疫苗及免疫疗法，核心上市产品为成人乙肝疫苗Heplisav-B，主要市场覆盖北美与欧洲，同时拥有多款针对未满足公共卫生需求的在研产品。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
DVAX vs RGP — 直观对比
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $94.9M | $117.7M |
| 净利润 | $26.9M | $-12.7M |
| 毛利率 | — | 37.1% |
| 营业利润率 | 22.4% | -10.3% |
| 净利率 | 28.4% | -10.8% |
| 营收同比 | 17.7% | -19.2% |
| 净利润同比 | 53.0% | 81.6% |
| 每股收益（稀释后） | $0.21 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $117.7M | ||
| Q3 25 | $94.9M | $120.2M | ||
| Q2 25 | $95.4M | $139.3M | ||
| Q1 25 | $68.2M | $129.4M | ||
| Q4 24 | $72.0M | $145.6M | ||
| Q3 24 | $80.6M | $136.9M | ||
| Q2 24 | $73.8M | $148.2M | ||
| Q1 24 | $50.8M | $151.3M |
| Q4 25 | — | $-12.7M | ||
| Q3 25 | $26.9M | $-2.4M | ||
| Q2 25 | $18.7M | $-73.3M | ||
| Q1 25 | $-96.1M | $-44.1M | ||
| Q4 24 | $7.0M | $-68.7M | ||
| Q3 24 | $17.6M | $-5.7M | ||
| Q2 24 | $11.4M | $10.5M | ||
| Q1 24 | $-8.7M | $2.5M |
| Q4 25 | — | 37.1% | ||
| Q3 25 | — | 39.5% | ||
| Q2 25 | — | 40.2% | ||
| Q1 25 | — | 35.1% | ||
| Q4 24 | — | 38.5% | ||
| Q3 24 | — | 36.5% | ||
| Q2 24 | — | 40.2% | ||
| Q1 24 | — | 37.0% |
| Q4 25 | — | -10.3% | ||
| Q3 25 | 22.4% | -1.7% | ||
| Q2 25 | 15.1% | -47.0% | ||
| Q1 25 | -34.7% | -38.4% | ||
| Q4 24 | -2.3% | -52.7% | ||
| Q3 24 | 12.5% | -3.5% | ||
| Q2 24 | 7.0% | 7.6% | ||
| Q1 24 | -35.0% | 2.8% |
| Q4 25 | — | -10.8% | ||
| Q3 25 | 28.4% | -2.0% | ||
| Q2 25 | 19.6% | -52.6% | ||
| Q1 25 | -141.0% | -34.0% | ||
| Q4 24 | 9.8% | -47.2% | ||
| Q3 24 | 21.8% | -4.2% | ||
| Q2 24 | 15.4% | 7.1% | ||
| Q1 24 | -17.2% | 1.7% |
| Q4 25 | — | $-0.38 | ||
| Q3 25 | $0.21 | $-0.07 | ||
| Q2 25 | $0.14 | $-2.21 | ||
| Q1 25 | $-0.77 | $-1.34 | ||
| Q4 24 | $0.07 | $-2.08 | ||
| Q3 24 | $0.12 | $-0.17 | ||
| Q2 24 | $0.08 | $0.31 | ||
| Q1 24 | $-0.07 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $160.2M | $89.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $534.1M | $194.6M |
| 总资产 | $946.5M | $289.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $89.8M | ||
| Q3 25 | $160.2M | $77.5M | ||
| Q2 25 | $99.1M | $86.1M | ||
| Q1 25 | $51.7M | $72.5M | ||
| Q4 24 | $95.9M | $78.2M | ||
| Q3 24 | $119.3M | $89.6M | ||
| Q2 24 | $112.5M | $108.9M | ||
| Q1 24 | $132.0M | $113.8M |
| Q4 25 | — | $194.6M | ||
| Q3 25 | $534.1M | $206.4M | ||
| Q2 25 | $494.2M | $207.1M | ||
| Q1 25 | $530.9M | $277.8M | ||
| Q4 24 | $596.8M | $325.7M | ||
| Q3 24 | $681.4M | $407.2M | ||
| Q2 24 | $642.8M | $418.8M | ||
| Q1 24 | $618.5M | $414.9M |
| Q4 25 | — | $289.3M | ||
| Q3 25 | $946.5M | $287.2M | ||
| Q2 25 | $918.4M | $304.7M | ||
| Q1 25 | $945.9M | $375.6M | ||
| Q4 24 | $986.3M | $424.9M | ||
| Q3 24 | $1.1B | $512.9M | ||
| Q2 24 | $1.0B | $510.9M | ||
| Q1 24 | $986.6M | $523.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.8M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | $32.6M | $15.6M |
| 自由现金流率自由现金流/营收 | 34.4% | 13.2% |
| 资本支出强度资本支出/营收 | 1.3% | 0.3% |
| 现金转化率经营现金流/净利润 | 1.26× | — |
| 过去12个月自由现金流最近4个季度 | $80.5M | $24.3M |
8季度趋势，按日历期对齐
| Q4 25 | — | $15.9M | ||
| Q3 25 | $33.8M | $-7.8M | ||
| Q2 25 | $23.4M | $16.8M | ||
| Q1 25 | $-19.6M | $659.0K | ||
| Q4 24 | $53.0M | $1.8M | ||
| Q3 24 | $19.5M | $-309.0K | ||
| Q2 24 | $10.7M | $3.2M | ||
| Q1 24 | $-16.7M | $20.5M |
| Q4 25 | — | $15.6M | ||
| Q3 25 | $32.6M | $-8.0M | ||
| Q2 25 | $22.0M | $16.5M | ||
| Q1 25 | $-23.6M | $238.0K | ||
| Q4 24 | $49.5M | $61.0K | ||
| Q3 24 | $18.1M | $-575.0K | ||
| Q2 24 | $9.9M | $3.0M | ||
| Q1 24 | $-17.4M | $20.4M |
| Q4 25 | — | 13.2% | ||
| Q3 25 | 34.4% | -6.6% | ||
| Q2 25 | 23.0% | 11.8% | ||
| Q1 25 | -34.6% | 0.2% | ||
| Q4 24 | 68.8% | 0.0% | ||
| Q3 24 | 22.5% | -0.4% | ||
| Q2 24 | 13.5% | 2.1% | ||
| Q1 24 | -34.3% | 13.5% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | 1.3% | 0.1% | ||
| Q2 25 | 1.5% | 0.2% | ||
| Q1 25 | 5.8% | 0.3% | ||
| Q4 24 | 4.8% | 1.2% | ||
| Q3 24 | 1.7% | 0.2% | ||
| Q2 24 | 1.1% | 0.1% | ||
| Q1 24 | 1.5% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 1.26× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 7.52× | — | ||
| Q3 24 | 1.11× | — | ||
| Q2 24 | 0.94× | 0.30× | ||
| Q1 24 | — | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DVAX
| HEPLISAVB | $90.0M | 95% |
| US Department Of Defense | $4.7M | 5% |
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
